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in Patients of Major Monopolar 
Depression
Hiroi Tomioka, Junichi Masuda, Akikazu Takada  
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Abstract
Plasma levels of tryptophan metabolites were compared between healthy vol-
unteers and patients of major monopolar depression at various ages and genders. 
An ultrahigh-speed liquid chromatography/mass spectrometry has been used 
for analysis. There are significant gender and age differences in TRP metabolites 
of healthy volunteers. At the upper stream of metabolism, metabolites of young 
women and old men are higher, but at the lower stream of metabolism, their 
levels are higher in young men and old women. Such differences disappear in 
plasma of patients of major monopolar depression except for kynurenine (KYN). 
Daily variation of blood serotonin (5-HT) levels showed that 5-HT levels were 
low in the morning and increased toward evening, but blood levels of 5-HT were 
higher in healthy people than depressive people in the morning and decreased to 
ward evening. Significant age and gender differences of plasma levels of trypto-
phan metabolites in healthy volunteers disappear in patients of major monopolar 
depression. Blood levels of 5-HT were higher in healthy people than depressive 
patients.
Keywords: depression, monopolar depression, bipolar depression, tryptophan, 
serotonin, 5-hydroxyindoleacetic acid, kynurenine, 3-hydroxykynurenine, 
kynurenic acid, anthranilic acid, xanthurenic acid, indole-3-acetic acid,  
selective serotonin reuptake inhibitor (SSRI), serotonin norepinephrine reuptake 
inhibitor (SNRI), anxiolytic, antipsychotic, and circadian variation
1. Introduction
Recently, it has been shown that both the responses to placebo and antide-
pressant increased [1]. Kirsch has claimed that pharmaceutical companies did 
not include mildly and moderately depressed patients in trials of efficacy after 
finding that these patients did not benefit beyond placebo [2]. He consistently 
insists that antidepressants are not more effective than placebos in moderately 
depressed patients [3]. Drug-placebo differences are considered to be small 
in efficacy trials, and most of the response to antidepressants seems due to 
expectancy [3].
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Major depressive disorder is one of the most common psychiatric disorders 
which is burdensome and costly worldwide in adults. Although pharmacologi-
cal and non-pharmacological treatments are available, because of inadequate 
resources, antidepressants are used more frequently than psychological 
interventions.
By using a meta-analysis, all antidepressants were shown more efficacious than 
placebo in adults with major depressive disorder. Smaller differences between 
active drugs were found when placebo-controlled trials were included in the 
analysis [4].
Serotonin (5-HT) has been indicated to be involved in etiology of depression [5].
The roles of various metabolites of kynurenine (KYN) pathway are reviewed [6], 
so we do not discuss these roles in detail.
As to relationships between serotonin levels and depression, we analyzed plasma 
levels of TRP metabolites in patients of depression.
Although the concentration of 5-HT has been considered to be low in depres-
sive patients [7], 5-HT concentration in the brains of suicide victims were not low 
[8]. Therefore, it is not known if 5-HT concentration is decreased in the brains of 
depressive patients.
We have recently succeeded in simultaneous measurements of TRP metabolites 
in plasma using an ultrahigh-speed liquid chromatography/mass spectrometry (LC/
MS) [9–12].
We now report age and gender differences of various TRP metabolites in patients 
of major monopolar depression and healthy volunteers.
2. Results
2.1  Comparison of plasma levels of TRP metabolites between healthy people 
and patients of major depression
2.1.1 Healthy volunteers
The sample sizes and ages of participants are as follows. Old men (n = 25; age, 
60.8 ± 9.9) and old women (n = 39; age, 67.4 ± 7.5) and young men (n = 49; age, 20.7 
± 1.5) and young women (n = 47; age, 21.2 ± 0.7). Characteristics of these people are 
described in Table 1.
Table 1. 
Background of healthy participants.
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2.1.2 Patients
Outpatients of depression were recruited in this study. Fasting blood  
samples were taken early in the morning. Their severity of depression was 
checked by clinical global impression—severity scale (CGI-S), SRS, and 
Hamilton depression rating scale (HDRS). The history of prescriptions of drugs 
such as antidepressants, anxiolytics, mood stabilizers, and other drugs were 
asked.
Sample numbers are 55 (male, 15; female, 40; average age, 45.4 ± 11.9). 
The number of MDD is 38 and BD is 17. Further characteristics of patients are 
described below.
Plasma factors were measured after plasma was separated from blood (3000 
rpm/min at 4°C). Ethylenediaminetetraacetic acid (EDTA) was used as an 
anticoagulant.
2.1.3 The simultaneous measurements of TRP metabolites in plasma
An ultrahigh-speed liquid chromatography/spectrometry was used for the assay. 
Although detailed methodology was described elsewhere [5–9], the important 
improvement of the assay method is described here.
2.1.3.1 Reagents and instrumentation
The simultaneous analytical method developed can be adapted to major metabo-
lites of TRP including melatonin in clinical sample.
The analytical targets of developed method are major metabolites, such 
as tryptophan (TRP), L-5-hydroxytryptophan (5-HTP), serotonin (5-HT), 
kynurenine (KYN), 5-hydroxy-tryptophol, tryptophol, 5-hydroxyindoleacetic 
acid (5-HIAA), indole-3-acetic acid, anthranilic acid (AA), kynurenic acid 
(KYNA), quinaldic acid, indole-3-butyric acid, 3-hydroxykynurenine (3-HKYN), 
3-hydroxyanthranilic acid (3-HAA), xanthurenic acid (XA), melatonin, and 
quinolinic acid (QA). Each compound was purchased from major chemical regent 
manufacturers, such as FUJIFILM Wako chemical (Osaka, Japan) and Sigma-
Aldrich (St. Louis, MO, USA).
Metabolite analysis was performed by a liquid chromatograph tandem mass 
spectrometer, the LCMS-8060 quadrupole mass spectrometer combined with 
Nexera X2 liquid chromatograph system (Shimadzu Corporation, Kyoto, Japan).
The targets are separated by reversed-phase chromatography using C18 
analytical column, L-Columns ODS2 (2.1 mm × 150 mm, CERI, Tokyo, Japan) 
with a gradient elution. Mobile phases were 0.1% formic acid solution and ace-
tonitrile with the gradient elution by 5% concentration of acetonitrile in 3 min 
and then 5–95% in 6 min, followed by 5% in 3 min at a total flow rate of 0.4 mL/
min. The temperature of the column was 40°C. Electrospray ionization (ESI) 
was used as mostly positive ionization with multi-reaction monitoring (MRM) 
detection.
Flow rate of the neutralizer and the drying gas were 2 L/min and 10 mL/min, 
respectively. Temperature of desolvation line (heated capitally tube) was 250°C. ESI 
interface was used at 400°C with 10 L/min of heating gas flow. Each MRM transi-
tion was optimized using each standard solution. Optimized results were shown in 
Table 1.
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All mother solutions of 1 mg/mL had been stocked under −80°C, and standard 
samples for calibration curve were prepared prior to use as mixture solution by 
consideration of each range of measurement concentration.
2.1.3.2 Analysis of human plasma
Aliquot of 50 μL human plasma was used for each sample analysis. The proce-
dure including deproteinization is shown in Figure 1.
TRP metabolic pathways are shown in Figure 1.
Figure 1 shows metabolic pathways of TRP. Metabolites were measured by an 
ultrahigh-speed liquid chromatography/mass spectrometry.
One-way ANOVA was used for evaluating statistical significance. A, b, c, and d indi-
cate values of young and old men and women. Tukey’s test was used for post hoc test.
Table 2 shows that there are significant gender and age differences in plasma 
levels of TRP of healthy volunteers.
Figure 1. 
Metabolic pathways of tryptophan.
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Generally speaking, plasma levels of 5-hydroxyindoleacetic acid (5-HIAA), 
indole-3-acetic acid (IAA), KYN, and AA are higher in young women and old men 
than in young men and old women. Plasma levels of XA and 3HK are higher in 
young men and old women than in young women and old men.
One-way ANOVA was used for evaluating statistical significance. A, b, c, and 
d indicate values of young and old men and women. Tukey’s test was used for post 
hoc test.
Table 3 shows that in contrast to cases in healthy people, age and gender differ-
ences disappeared in MMD except for KYN.
Table 2. 
Measurements of plasma levels of TRP metabolites in healthy volunteers.
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3. Discussion of part 1
The availability of endogenous 5-HT as a neurotransmitter is crucial in many 
physiological processes. Serotonergic neurons in the central nervous system are 
involved in regular behavioral states and physiological processes including arousal, 
Table 3. 
TRP metabolite levels of patients of MMD.
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sleep, appetite, pain, releases of hormone, and mood. Dysfunction of 5-HT neurons 
may lead to depression and other mental disorders.
Many scientific research has been done to know roles of 5-HT in pathophysiol-
ogy of depression.
Since pathological changes are investigated in the brain and cerebrospinal fluid 
of suicides, it is claimed that 5-HT neurotransmission is implicated in the causes of 
suicide [13, 14]. Low levels of 5-HIAA in cerebrospinal fluid were shown in suicide 
attempters of depression [15]. Although the brainstem of suicide attempters had 
less 5-HT and 5-HIAA, most postmortem studies report no differences in cortical 
5-HT or 5-HIAA of suicides [16].
Furthermore [17] patients with MDD have been reported to have higher 5-HIAA 
in jugular venous blood and have been argued to reflect higher brain 5-HT neuro-
transmission and turnover [18].
So the roles of 5-HT in depression is still confusing.
We simultaneously analyzed plasma levels of TRP metabolites in healthy people 
and patients of MMD. As shown in Tables 2 and 3, significant age and gender dif-
ferences disappear in patients of MMD.
It is difficult to speculate reasons of such changes in MMD. Probably, hormonal 
changes may be implicated.
These results suggest that much attention has to be paid to age and gender if we 
want to analyze TRP metabolites, especially 5-HT and 5-HIAA.
Statistical differences of TRP metabolites between MMD or BD and healthy 
people will be reported elsewhere.
3.1 The diurnal variation of 5-HT in the blood of patients of depression
As stated above, serotonin (5-HT) plays roles in a state of depression since 
selective inhibitors of the uptake of 5-HT and the blockers of 5-HT 1A receptors are 
effective in its treatment [19, 20].
There is some evidence indicating that in patients of affective disorders, the 
regulation of circadian rhythms is disturbed [21].
We have shown that plasma levels of 5-HT were very low in patients of 
depression, but the levels of 5-HIAA or KYN were not different from the 
levels of control persons suggesting that 5-HT was immediately converted to 
5-HIAA in patients of depression [9]. Due to the presence of 5-HT transporter 
in platelet membranes, most of 5-HT are believed to be stored in platelets in the 
blood [22].
We have shown that whole blood 5-HT concentration showed marked changes 
throughout daytime, with maximum values in the evening and lowest values in the 
morning, whereas its metabolite 5-HIAA followed contrary [23].
So we wanted to measure 5-HT levels in the blood of patients of depression and 
controls.
We examined at five timepoints whole blood 5-HT levels in depressive patients 
of Hamamatsu University Hospital and control volunteers. The number of depres-
sive patients was 18 and 30 volunteers.
Patients were in depressive states as confirmed by a mean score of 18.7 (range 
12–24) on the 24-item scale of Hamilton depression rating scale [24]. None of them 
were administered with any drug except for small doses of benzodiazepines, for at 
least 10 days before blood was taken.
Blood levels of 5-HT were measured using HPLC as described by Anderson et al 
[25]. Analytical recoveries were 85% (SD 4.5%, CV 5.6%). Amount and response 
were nearly related.
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As shown in Figure 2, whole blood 5-HT levels were significantly lower in 
depressed patients at 8:30 10:30, 12:30, and 14:30. The blood concentration of 5-HT 
showed a circadian variation.
In the group of depression, the lowest value was shown at 8:30 and the level 
progressively increased to 14:30.
4. Discussion of part 2
Platelet 5-HT content is most likely regulated by the platelet transport activity.
Variations of 5-HT uptake in depressed patients have been reported by several 
groups [26–28].
Seasonal changes of serotonin (5-HT) uptake in blood platelets from depressed 
patients and normal controls were studied over a 2-year period to know if seasonal 
variations were present [26]. A measure of the number of 5-HT uptake sites in nor-
mal controls and depressed patients was significantly higher in fall and winter than 
in spring and summer. The number of 5-HT uptake in the depressed patients was 
lower than in normal controls throughout the year. Normal controls showed lower 
number in April and June. A similar trend was present in the depressed patients but 
the lowest values were found in the month of December.
Blood levels of melatonin, 5-HT, cortisol, prolactin, and serotonin uptake by 
platelets were measured at 08:00 to 08:00 hours of the following day in healthy men 
in age from 27 to 35 years [27]. The active transport of 5-HT by platelets was shown 
to be significantly correlated with melatonin blood levels. This finding suggests 
either a direct effect of melatonin on 5-HT active transport or the influence of the 
suprachiasmatic nucleus on serotonin uptake by platelets.
So far depressive disorders are considered to be associated with various neuro-
biological alterations like hyperactivity of the hypothalamic-pituitary-adrenal axis, 
altered neuroplasticity, and altered circadian rhythms. Unfortunately, the causal 
Figure 2. 
Diurnal variation of blood serotonin levels of healthy men and patients of major depression. Ordinate, blood 
levels of 5-HT; abscissa, time when blood was taken. **p < 0.01 control vs. depression, *0.05, levels at 8:30 vs. 
10.30 of depressive patients.
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connections between depressive disorders and disturbed circadian rhythms have 
not been completely clarified. Chronobiological therapy is based on these disturbed 
processes. For the treatment of the circadian symptoms, various scientifically tested 
chronotherapeutics are available with different effectiveness and evidence like light 
therapy or sleep deprivation. The successful treatment of depression also frequently 
leads to an improvement in altered circadian rhythm.
Further studies of circadian variation of 5-HT system may help to understand 
the control of serotonergic nervous system and the treatment of depression.
Abbreviations
TRP tryptophan
5-HT serotonin
5-HIAA 5-hydroxyindoleacetic acid
IAA indole-3-acetic acid
KYN kynurenine
XA xanthurenic acid
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KNA kynurenic acid
3-HKN 3-hydroxykynurenine
IDO indoleamine dioxygenase
TDO tryptophan dioxygenase
SSRI selective serotonin uptake inhibitor
SNRI serotonin epinephrine reuptake inhibitor
CGI-S clinical global impression—severity scale
SDS self-rating depression scale
HDRS Hamilton depression rating scale
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